Mechanisms and consequences of extrafollicular B cell activation during malaria
疟疾期间滤泡外 B 细胞激活的机制和后果
基本信息
- 批准号:10494205
- 负责人:
- 金额:$ 64.71万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-24 至 2026-08-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAffectAffinityAmino Acid TransporterAmino AcidsAntigensAntimalarialsB-Cell ActivationB-LymphocytesBiochemicalBloodCOVID-19Cell physiologyCellsCellular Metabolic ProcessCessation of lifeCommunicable DiseasesDataDengueDetectionDevelopmentDietDiseaseEbolaEpigenetic ProcessEventFailureGeneticGenetic TranscriptionGlutamineGoalsHumanHumoral ImmunitiesHyperactivityHypoxiaImmuneImmune responseImmunityImmunologic MemoryImmunologyImpairmentIndividualInfectionInfectious Disease ImmunologyInterferonsInterventionKnowledgeLinkLongevityLongitudinal StudiesMalariaMediatingMemory B-LymphocyteMetabolicMetabolismMolecularMusNatureNutrientParasitesPathway interactionsPatientsPattern recognition receptorPlasma CellsPlasmablastPlasmodiumPopulationProtozoan InfectionsReagentReceptor SignalingReportingResistanceResolutionShapesSignal TransductionSpleenStructure of germinal center of lymph nodeSupplementationSystemTestingTrypanosomiasisbaseimprintimprovedinnovationnovelnovel strategiesnutrient deprivationpathogenplasma cell developmentprogramsresponsesingle cell technologytoolvaccinology
项目摘要
ABSTRACT
There is currently a lack of mechanistic understanding of why humoral immunity against malaria is not efficiently
induced and why Plasmodium infections are associated immune failures, even following repeated infections. Our
long-term goal is to determine how Plasmodium parasites, and potentially other protozoan infections, co-opt and
subvert humoral immunity, which will help with the identification and development of new immune-based
interventions against devastating diseases like malaria. The objectives of this project are to define mechanisms
that trigger initial humoral immune dysregulation and study the consequences of these events on the formation
of durable humoral immune memory. Our central hypothesis is that robust humoral immunity does not develop
efficiently because polyclonal B cell activation events establish a nutrient sink that impairs the metabolic,
transcriptional and epigenetic programming and function of Plasmodium-specific memory B cells. The rationale
for this project is linked to our recent discovery that Plasmodium infection results in a massive polyclonal
expansion of B cells that function as a nutrient sink that limits protective memory B cell responses. Deletion of
these B cells accelerates blood-stage Plasmodium parasite clearance and enhances humoral immune
memory. Supplementing the diet of infected mice with a single amino acid is sufficient to overcome the nutrient
sink and metabolic constraints imposed by these B cells and results in enhanced humoral immune memory
responses. Despite our new findings, the molecular mechanisms governing the activation and function of
immunoinhibitory B cells and the impact of these cells on the affinity and longevity of memory B cells remain
critical knowledge gaps in our quest to improve humoral immunity against malaria. Two Aims address these
priority questions. In the first Aim we will determine the molecular and cellular mechanisms that govern the
expansion of these immunosuppressive B cells and investigate whether these populations are relevant to other
infections associated with dysregulated humoral immunity. In the second Aim we will investigate the molecular
and cellular consequences of immunosuppressive B cell expansions on the genetic and epigenetic programming
of memory B cells. We have developed several innovative new reagents that afford unprecedented resolution
for the study anti-malarial humoral immunity. The significance of this project is directly linked to our new findings
showing that pathophysiological changes that occur during Plasmodium infection durably imprints on B cell fate
and function. Thus, determining how these pathways coordinately regulate polyclonal B cell activation,
development and humoral immunity will be broadly important to those studying infectious disease immunology
and vaccinology.
抽象的
目前对于为什么针对疟疾的体液免疫不能有效地缺乏机制理解
以及为什么疟原虫感染与免疫失败相关,即使是在重复感染后也是如此。我们的
长期目标是确定疟原虫寄生虫以及潜在的其他原生动物感染如何共同选择和传播
颠覆体液免疫,这将有助于识别和开发新的基于免疫的
针对疟疾等毁灭性疾病的干预措施。该项目的目标是定义机制
引发最初的体液免疫失调并研究这些事件对形成的影响
持久的体液免疫记忆。我们的中心假设是,强大的体液免疫不会发展
有效地,因为多克隆 B 细胞激活事件建立了一个损害代谢的营养库,
疟原虫特异性记忆 B 细胞的转录和表观遗传编程和功能。理由
这个项目与我们最近的发现有关,即疟原虫感染会导致大量的多克隆
B 细胞的扩张充当营养库,限制保护性记忆 B 细胞的反应。删除
这些 B 细胞可加速血液阶段疟原虫寄生虫的清除并增强体液免疫
记忆。在受感染小鼠的饮食中补充单一氨基酸就足以克服营养不良
这些 B 细胞施加的库和代谢限制,导致体液免疫记忆增强
回应。尽管我们有新的发现,但控制激活和功能的分子机制
免疫抑制性 B 细胞以及这些细胞对记忆 B 细胞的亲和力和寿命的影响仍然存在
我们在寻求提高针对疟疾的体液免疫力方面存在关键的知识差距。有两个目标解决这些问题
优先问题。在第一个目标中,我们将确定控制细胞的分子和细胞机制。
扩增这些免疫抑制性 B 细胞,并研究这些细胞群是否与其他细胞相关
与体液免疫失调相关的感染。在第二个目标中,我们将研究分子
免疫抑制 B 细胞扩增对遗传和表观遗传编程的细胞影响
记忆B细胞。我们开发了多种创新试剂,可提供前所未有的分辨率
用于研究抗疟疾体液免疫。该项目的重要性与我们的新发现直接相关
表明疟原虫感染期间发生的病理生理变化持久地影响 B 细胞的命运
和功能。因此,确定这些途径如何协调调节多克隆 B 细胞激活,
发育和体液免疫对于研究传染病免疫学的人来说非常重要
和疫苗学。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Noah Sullivan Butler其他文献
Noah Sullivan Butler的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Noah Sullivan Butler', 18)}}的其他基金
Defining the effect of Plasmodium infection on Ebola virus vaccine efficacy
确定疟原虫感染对埃博拉病毒疫苗功效的影响
- 批准号:
10681616 - 财政年份:2023
- 资助金额:
$ 64.71万 - 项目类别:
Mechanisms and consequences of extrafollicular B cell activation during malaria
疟疾期间滤泡外 B 细胞激活的机制和后果
- 批准号:
10686400 - 财政年份:2021
- 资助金额:
$ 64.71万 - 项目类别:
Mechanisms and consequences of extrafollicular B cell activation during malaria
疟疾期间滤泡外 B 细胞激活的机制和后果
- 批准号:
10376468 - 财政年份:2021
- 资助金额:
$ 64.71万 - 项目类别:
Development and function of CD4+ memory T cells during malaria
疟疾期间 CD4 记忆 T 细胞的发育和功能
- 批准号:
10604910 - 财政年份:2016
- 资助金额:
$ 64.71万 - 项目类别:
Development and function of CD4+ memory T cells during malaria
疟疾期间 CD4 记忆 T 细胞的发育和功能
- 批准号:
9157297 - 财政年份:2016
- 资助金额:
$ 64.71万 - 项目类别:
Regulation of Plasmodium-specific CD4+ T Cells
疟原虫特异性 CD4 T 细胞的调节
- 批准号:
9214981 - 财政年份:2016
- 资助金额:
$ 64.71万 - 项目类别:
Regulation of Plasmodium-specific CD4+ T cells
疟原虫特异性 CD4 T 细胞的调节
- 批准号:
10676649 - 财政年份:2016
- 资助金额:
$ 64.71万 - 项目类别:
Role of CD4 T cell inhibitor receptors during Plasmodium blood stage infection
CD4 T 细胞抑制剂受体在疟原虫血期感染过程中的作用
- 批准号:
8442603 - 财政年份:2013
- 资助金额:
$ 64.71万 - 项目类别:
Role of CD4 T cell inhibitor receptors during Plasmodium blood stage infection
CD4 T 细胞抑制剂受体在疟原虫血期感染过程中的作用
- 批准号:
8607494 - 财政年份:2013
- 资助金额:
$ 64.71万 - 项目类别:
相似国自然基金
线上民宿房东亲和力对房客预定行为的影响机制研究——基于多源异构数据视角
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
估计和解释序列变体对蛋白质稳定性、结合亲和力以及功能的影响
- 批准号:31701136
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
RGS19对嗜酸细胞性食管炎FcεRI信号传导通路的影响及其作用机制的研究
- 批准号:81500502
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
人B组腺病毒纤毛蛋白与DSG2受体亲和力的差异及其对病毒致病力的影响研究
- 批准号:31570163
- 批准年份:2015
- 资助金额:62.0 万元
- 项目类别:面上项目
TNFalpha-OPG相互作用对骨代谢的影响
- 批准号:30340052
- 批准年份:2003
- 资助金额:9.0 万元
- 项目类别:专项基金项目
相似海外基金
SELENOF is a Novel Tumor Suppressor and a New Target to Overcome Racial Disparity in Breast Cancer.
SELENOF 是一种新型肿瘤抑制剂,也是克服乳腺癌种族差异的新靶点。
- 批准号:
10735662 - 财政年份:2023
- 资助金额:
$ 64.71万 - 项目类别:
Understanding and Targeting Host Processes Essential to Plasmodium Infection
了解并针对疟原虫感染所必需的宿主过程
- 批准号:
10735130 - 财政年份:2023
- 资助金额:
$ 64.71万 - 项目类别:
Pilot Studies of PAX3-FOXO1 Fusions Proteins in Alveolar Rhabdomyosarcoma
PAX3-FOXO1 融合蛋白在肺泡横纹肌肉瘤中的初步研究
- 批准号:
10726763 - 财政年份:2023
- 资助金额:
$ 64.71万 - 项目类别:
Investigating how bHLH circuits integrate signals for cell fate decisions
研究 bHLH 电路如何整合信号以决定细胞命运
- 批准号:
10722452 - 财政年份:2023
- 资助金额:
$ 64.71万 - 项目类别:
Growth plate-targeted IGF1 to treat Turner Syndrome
生长板靶向 IGF1 治疗特纳综合征
- 批准号:
10819340 - 财政年份:2023
- 资助金额:
$ 64.71万 - 项目类别: